GOODWILL AND INTANGIBLES ASSETS, NET

6 Months Ended

Jun. 30, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS, NET

Information regarding the Company’s other intangible assets are as follows (in thousands):



	June 30, 2018							December 31, 2017
	Gross Amount		Accumulated Amortization			Net Amount		Gross Amount		Accumulated Amortization			Net Amount
Indefinite-lived intangible assets:
Tradenames	$	287,427	$	—		$	287,427	$	225,600	$	—		$	225,600
Finite-lived intangible assets:
Customer relationships	74,910		(14,551		)	60,359		22,497		(11,575		)	10,922
Copyrights & design	9,542		(618		)	8,924		—		—			—
Various	13,378		(10,586		)	2,792		12,088		(10,029		)	2,059
Total	$	385,257	$	(25,755	)	$	359,502	$	260,185	$	(21,604	)	$	238,581

The Company’s amortization expense, which is recorded on a straight-line basis, related to finite-lived intangible assets was $2.2 million and $4.1 million for the three and six months ended June 30, 2018 and $0.8 million and $1.6 million for the three and six months ended June 30, 2017, respectively. The expected amortization expense based on the finite-lived intangible assets as of June 30, 2018 are as follows (in thousands):



	Estimated Amortization
Remainder of 2018	$	4,421
2019	8,804
2020	8,731
2021	8,206
2022	7,881

The changes in the carrying amount of goodwill by reportable segment are as follows (in thousands):



	Office Segment			Lifestyle Segment			Total
Balance as of December 31, 2017	$	36,220		$	105,893		$	142,113
Foreign currency translation adjustment	(335		)	(9,235		)	(9,570		)
Goodwill acquired	—			193,813			193,813
Balance as of June 30, 2018	$	35,885		$	290,471		$	326,356

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details